Boston Scientific Corp. has purchased M.I.Tech, a manufacturer and distributor of medical devices.
M.I.Tech is the creator of the HANAROSTENT technology, a family of conformable, non-vascular metal stents.
“M.I.Tech is an innovator in non-vascular stent development, with product offerings that complement our existing stent portfolio,” said Art Butcher, executive vice president and group president, MedSurg and Asia Pacific, Boston Scientific. “We are committed to investing in technologies that advance care for patients around the world and are eager to work more closely with M.I.Tech to expand their international footprint.”